Lexology February 16, 2023
Introduction
On February 1, 2023, the Centers for Medicare & Medicaid Services (“CMS”) published a long-awaited and controversial final rule that implements technical changes to the Medicare Advantage (“MA”) contract-level Risk Adjustment Data Validation (“RADV”) program (the “RADV Final Rule”).1
Following years of proposed rules, public comment, and litigation, the RADV Final Rule contains three key takeaways that will impact MA stakeholders:
- It implements extrapolation of RADV audit findings commencing payment year (“PY”) 2018;2
- It rejects a Fee-For-Service (“FFS”) adjuster for MA risk adjustment that would have limited the financial impact of the RADV Final Rule for Medicare Advantage Organizations (“MAOs”); and
- It clarifies that MA overpayment self-reporting and repayment requirements for MAOs will be forthcoming from CMS.